A regulatory science viewpoint on botanical–drug interactions
There is a continued predisposition of concurrent use of drugs and botanical products. Consumers often self-administer botanical products without informing their health care providers. The perceived safety of botanical products with lack of knowledge of the interaction potential poses a challenge fo...
Main Authors: | Manuela Grimstein, Shiew-Mei Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-04-01
|
Series: | Journal of Food and Drug Analysis |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1021949818300425 |
Similar Items
-
National seminar on "regulatory and quality aspects of herbal drugs and botanicals"
by: Sayeed Ahmad
Published: (2015-01-01) -
US regulatory approaches to chemistry, manufacturing, and controls for botanical drug products
by: Agarwal Rajiv
Published: (2012-10-01) -
Draft amendment to drugs and cosmetics rules to license science based botanicals, Phytopharmaceuticals as drugs in India
by: D B Anantha Narayana, et al.
Published: (2013-01-01) -
Uniting botanical science and art
by: Brian W. van Wilgen
Published: (2020-05-01) -
Botanical Drugs and Stem Cells
by: Po-Cheng Lin, et al.
Published: (2011-02-01)